Chattopadhyay Sanat
SEC CIK 1670690 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck & Co. | Exe V-P, Pres. MMD | 16.5K | — | $37.05M | 15 | 2021-10-29 | 2026-04-29 |
Most active insiders at MRK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Zachary Jennifer | EVP, GC | — | $25.20M |
| 2 | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | — | $11.29M |
| 3 | Guindo Chirfi | EVP, Access, Policy, Comms | — | $8.15M |
| 4 | Williams David Michael | EVP, Chief Info, Digital Off | — | $8.13M |
| 5 | Davis Robert M | COB, CEO, Pres, Dir | — | $5.60M |
| 6 | Litchfield Caroline | EVP, CFO | — | $5.02M |
| 7 | Li Dean Y | Pres, Executive VP, MRL | — | $2.99M |
| 8 | Maraldo David R. | EVP, Pres. MMD | — | $2.41M |
| 9 | Oosthuizen Johannes Jacobus | Pres, U.S. Market | — | $1.83M |
| 10 | Smart Dalton E. III | SVP Fin. - Gbl Ctrl | — | $766.0K |
| 13 | Chattopadhyay Sanat | Exe V-P, Pres. MMD | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-01 18:32 | 2026-04-29 | MRK | Merck & Co. | Chattopadhyay Sanat | Exe V-P, Pres. MMD | M - OptEx | $110.03 | +2,597 | 16.5K | +19% | +$285.7K |
| D | 2026-05-01 18:32 | 2026-04-29 | MRK | Merck & Co. | Chattopadhyay Sanat | Exe V-P, Pres. MMD | F - Tax | $110.03 | -1,130 | 15.3K | -7% | -$124.3K |
| 2026-01-28 | 2026-01-26 | MRK | Merck & Co. | Chattopadhyay Sanat | Exe V-P, Pres. MMD | A - Grant | $107.40 | +13.9K | 13.9K | New | +$1.49M | |
| 2025-01-29 | 2025-01-27 | MRK | Merck & Co. | Chattopadhyay Sanat | Exe V-P, Pres. MMD | A - Grant | $97.94 | +28.1K | 78.8K | +56% | +$2.76M | |
| 2024-01-24 | 2024-01-22 | MRK | Merck & Co. | Chattopadhyay Sanat | Exe V-P, Pres. MMD | A - Grant | $119.43 | +26.7K | 26.7K | New | +$3.19M | |
| DM | 2023-04-14 | 2023-04-13 | MRK | Merck & Co. | Chattopadhyay Sanat | Exe V-P, Pres. MMD | M - OptEx | $59.02 | +134.1K | 67.9K | New | +$7.91M |
| DM | 2023-04-14 | 2023-04-13 | MRK | Merck & Co. | Chattopadhyay Sanat | Exe V-P, Pres. MMD | S - Sale+OE | $115.07 | -134.1K | 67.9K | -66% | -$15.43M |
| 2023-01-25 | 2023-01-23 | MRK | Merck & Co. | Chattopadhyay Sanat | Exe V-P, Pres. MMD | A - Grant | $109.88 | +17.5K | 47.0K | +59% | +$1.92M | |
| DM | 2023-01-11 | 2023-01-09 | MRK | Merck & Co. | Chattopadhyay Sanat | Exe V-P, Pres. MMD | S - Sale+OE | $112.29 | -84.0K | 69.4K | -55% | -$9.43M |
| D | 2023-01-11 | 2023-01-09 | MRK | Merck & Co. | Chattopadhyay Sanat | Exe V-P, Pres. MMD | M - OptEx | $53.06 | +84.0K | 113.5K | +285% | +$4.46M |
| DM | 2022-11-01 | 2022-10-28 | MRK | Merck & Co. | Chattopadhyay Sanat | Exe V-P, Pres. MMD | M - OptEx | $0.00 | +100.3K | 145.9K | +220% | $0 |
| D | 2022-11-01 | 2022-10-28 | MRK | Merck & Co. | Chattopadhyay Sanat | Exe V-P, Pres. MMD | S - Sale+OE | $100.10 | -100.3K | 45.6K | -69% | -$10.04M |
| 2022-02-28 | 2022-02-24 | MRK | Merck & Co. | Chattopadhyay Sanat | Exe V-P, Pres. MMD | A - Grant | $73.51 | +19.8K | 113.0K | +21% | +$1.46M | |
| D | 2021-11-02 | 2021-10-29 | MRK | Merck & Co. | Chattopadhyay Sanat | Exe V-P, Pres. MMD | S - Sale+OE | $87.32 | -24.6K | 93.1K | -21% | -$2.15M |
| D | 2021-11-02 | 2021-10-29 | MRK | Merck & Co. | Chattopadhyay Sanat | Exe V-P, Pres. MMD | M - OptEx | $0.00 | +24.6K | 117.8K | +26% | $0 |
Purchase Sale Sale after option exercise All abbreviations